New York Times Article Spotlights Potential Role of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New York Times Article Spotlights Potential Role of Metabolism-Centered Therapies in Fighting Cancer

NEW YORK, June 01, 2016 (GLOBE NEWSWIRE) -- According to Tyme Technologies, Inc. (OTCQB:TYMI), a clinical-stage pharmaceutical company focused on discovering and developing highly targeted cancer therapeutics for a broad range of oncology indications, conclusions cited in the May 15, 2016, New York Times Magazine article, “An Old Idea, Revived: Starve Cancer to Death,” support the science behind its proprietary compound, SM-88.

The Times article describes the original research conducted by Nobel Prize winner Otto Warburg on what is effectively cancer cells’ damaged metabolic reliance on glucose rather than more efficient respiration involving oxygen. While Warburg’s work was generally praised, his discoveries were soon overshadowed by new discoveries in gene therapy. However, as the article points out, “Even James Watson, one of the fathers of molecular biology, is convinced that targeting metabolism is a more promising avenue in current cancer research than gene-centered approaches.” Ultimately, experts agree that this may be the key to cancer’s vulnerability.

“We find it very promising that the scientific community is focused on the potential of this type of cancer-fighting therapy and has validated the importance of targeting cancer cell metabolism. SM-88 is a drug candidate with a unique metabolic approach, and this timely article is especially encouraging in highlighting the latest scientific thinking,” said Michael Demurjian, Chief Operating Officer, Tyme Technologies.

Late last year, Tyme submitted a Phase 2 Investigational New Drug (IND) Application to the U.S. Food and Drug Administration (FDA) for SM-88, which is designed to synergistically target the unique metabolic features of cancer cells and selectively alter the susceptibility of cancer cells to oxidative stress. Tyme is currently in discussions with the FDA regarding advancing SM-88.

Tyme is currently focused on commencing its next round of clinical studies with a study in prostate cancer by the third quarter of 2016. This will be part of a program of multiple studies of SM-88 across various indications, including those in breast and pancreatic cancers. Tyme has previously reported activity in women’s cancers including breast cancer.

About Tyme

Tyme’s research and development efforts are based on a proprietary platform technology, for which it retains global Intellectual Property (IP) and commercial rights. SM-88 is believed to be a first-in-class oncology therapy that increases the power of the body’s innate defenses to utilize oxidative stress to kill cancer cells. It is designed to penetrate only living cancer cells without toxic effects and without involving healthy body tissue. Its therapeutic potential is based on its ability to increase the availability of free radicals and promote their entry into cancer cells by stripping the cancer cells of their normal barriers to these toxic electrons. SM-88 is a combination of a proprietary novel molecule with three currently marketed drugs that are generally considered safe for their already-approved indications in areas other than cancer treatment.  

For more information, visit:  www.tymetechnologiesinc.com .

Forward-Looking Statements

In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding Tyme’s future performance, and readers can identify forward-looking statements by sentences or passages involving the use of terms such as "anticipates," "believes," “designed,” "could," "estimates," "expects," "intends," "may," "plans," "potential," "predicts," "projects," "should," "would" and similar expressions intended to identify forward-looking statements. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of Tyme’s control. Forward-looking statements within this press release include, without limitation, statements regarding our drug development strategies, the therapeutic mechanisms of our drug candidates and our completed and planned clinical trials. These statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any historical results and future results, performances or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to, the factors described in the section captioned "Risk Factors" of Tyme's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 30, 2016 (available at www.sec.gov ).

Lisa M. Wilson, In-Site Communications, Inc. lwilson@insitecony.com 917-543-9932

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roland DG's Brand Refresh Earns Three B2B Awards in 2026

Updated Category News Views 98

Three trophies for a printer-maker’s marketing overhaul will not move mountains by themselves, but they do tell us Roland DG has stopped treating its brand like an afterthought. The company’s global Make Your Mark refresh picked up two Silver awards and one Bronze at the 2026 Drum B2B Awards in Miami. For a business selling industrial-grade tools into crowded,...

Continue Reading
Layne’s Jacksonville Debut Tests East Texas Expansion

Updated Category News Views 57

Jacksonville is not some flashy coastal launch, and that is precisely why this Layne’s Chicken Fingers opening matters. A new chicken tender shop at 1217 S. Jackson St. will not move public markets, because this is a franchise-growth story rather than a ticker story. But it does offer a clean look at whether Layne’s can turn its Texas roots into a durable multi-market...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 142

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 77

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 92

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables

Updated Category News Views 141

A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...

Continue Reading
MetaOptics Tests a Real Path Into Secure Imaging Markets

Updated Category News Views 84

Fingerprint scanners have never impressed me much; fooling one is exactly the sort of nuisance that keeps security buyers spending. MetaOptics’ new collaboration with Hong Kong’s ASTRI goes after that uncomfortable problem with a compact nano-optics imaging system built for biometric security and smart sensing. It is a sensible target. It is also, at this stage, a...

Continue Reading
Seeking Alpha Premium Review: Data Meets Human Judgment

Updated Category News Views 159

A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 114

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
24X Options Filing Puts Earnings Bets Before the SEC

Updated Category News Views 121

An earnings release already turns the market into a bar fight; 24X wants to put part of that fight inside a regulated binary-options contract. The Stamford-based exchange has filed a proposed rule change with the SEC for 24X Options, a facility that would offer a conventional options market alongside contracts tied to company performance targets. It is an interesting...

Continue Reading

Top 5 Most Recently Viewed Articles

BW Offshore Announces Ex Dividend of USD 0.0625 for Shareholders

Updated Category News Views 145

BW Offshore Announces Ex Dividend for Shareholders BW Offshore Limited is excited to announce that its shares will be trading ex dividend at USD 0.0625 per share. This important announcement marks the beginning of a new dividend cycle for our valued shareholders. Upcoming Dividend Payment The dividend payment is scheduled to occur around November 28, ensuring that our...

Continue Reading
Empowering the Hispanic Community in Home Buying Efforts

Updated Category News Views 93

Sun Title Launches Initiative for Hispanic Home Buyers In a notable move to foster inclusivity in the real estate market, Sun Title has introduced a comprehensive initiative aimed at empowering Hispanic home buyers and sellers. This effort is designed to support individuals in the Hispanic community, helping them navigate the often complex processes involved in buying or...

Continue Reading
Fluence Energy Delivers Impressive Q4 Results and Growth Insights

Updated Category News Views 312

Fluence Energy Q4 Earnings Overview Fluence Energy (NASDAQ: FLNC) recently shared its earnings results for the fourth quarter, bringing forth exciting news for investors. The performance exceeded expectations, indicating positive upward momentum. Highlights from the Earnings Call In an announcement made recently, Fluence Energy reported an earnings per share (EPS) of...

Continue Reading
How Buck Sexton Highlights Leadership in the AI Arms Race

Updated Category News Views 287

The Urgency of the AI Arms Race In a recent interview, former CIA officer Buck Sexton shared alarming insights into America's current position in the race for Artificial Superintelligence. He emphasizes that this is not just about technology, but about America's future as a global leader. He suggests that we are currently in a precarious situation, as other nations,...

Continue Reading
Finastra Gains Leader Spot in Digital Banking 2026

Updated Category News Views 48

When it comes to digital banking, not every player gets the spotlight, but Finastra? They're not just basking in it—they're standing on top of the podium as a Leader in the SPARK Matrix™: Digital Banking Platform 2026 by QKS Group. Why Finastra Shines Bright Now, Finastra ain't some overnight sensation. They’ve been hammering away at the digital banking world with...

Continue Reading